Preparation and Characterization of Stable Amorphous Glassy Solution of BCS II and IV Drugs
- 23 December 2021
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 23 (1) , 1-12
Abstract
The focus of the present investigation was to develop amorphous glassy solutions (AGSs) of BCS Class II and IV drugs using sucrose acetate isobutyrate (SAIKeywords
This publication has 47 references indexed in Scilit:
- Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approachInternational Journal of Pharmaceutics, 2013
- Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction TimesCrystal Growth & Design, 2012
- Improvement of Physicochemical Properties of an Antiepileptic Drug by Salt EngineeringAAPS PharmSciTech, 2012
- Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluationInternational Journal of Pharmaceutics, 2010
- Amorphous Compositions Using Concentration Enhancing Polymers for Improved Bioavailability of ItraconazoleMolecular Pharmaceutics, 2008
- Enhanced In Vivo Absorption of Itraconazole via Stabilization of Supersaturation Following Acidic-to-Neutral pH TransitionDrug Development and Industrial Pharmacy, 2008
- Sucrose acetate isobutyrate as an In Situ forming system for sustained risperidone releaseJournal of Pharmaceutical Sciences, 2007
- Cyclodextrins and their pharmaceutical applicationsInternational Journal of Pharmaceutics, 2007
- Principal component analysis for characterising homogeneity in powder mixing using image processing techniquesChemical Engineering and Processing - Process Intensification, 2006
- INFRARED SPECTROSCOPY | Near-Infrared2005